TP53 and lung adenocarcinoma: Adding recombinant human p53 adenovirus injection improves the radiosensitivity of lung adenocarcinoma, and rAd-p53 plus cisplatin chemotherapy resulted in a significantly higher short-term efficacy than cisplatin alone in treating malignant pleural or abdominal effusions.